Alexion Pharmaceuticals Becomes #42 Most Shorted Nasdaq 100 Component, Replacing KLA-Tencor

The most recent short interest data has been released by the NASDAQ for the 03/28/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

START SLIDESHOW:
The 25 Most Shorted Nasdaq 100 Stocks »

In our new rank based on the most recent short interest data from NASDAQ, Alexion Pharmaceuticals Inc. (ALXN) ALXN has taken over the position of #42 most shorted Nasdaq 100 component, from KLA-Tencor Corp. (KLAC) KLAC which is now in the #57 spot. The "days to cover" at 03/28/2013 was 3.11 for ALXN, and 2.26 for KLAC; this compares to the average across all Nasdaq 100 components of 4.15 (up from the average back on the 03/15/2013 settlement date of 3.66). The chart below shows the movement over time of the "days to cover" values of both ALXN and KLAC, versus the average Nasdaq 100 component.

Loading+chart++2012+TickerTech.com

Below is a chart showing the relative positions of ALXN versus KLAC over time within the 100 Nasdaq 100 components, with #1 representing the component with the highest "days to cover" value (most heavily shorted) and #100 representing the component with the lowest "days to cover" value (least heavily shorted):

If you liked this article you might like

Alexion Could Target Sage, Ra Pharma: Analyst

Dow, S&P 500 and Nasdaq at New Records as Promise of Tax Reform Boosts Banks

Stocks Back at Highs as Apple Gains on iPhone 8, iPhone X Release

Tech in Wait-and-See Mode Ahead of Apple Event, Financials Rise on Tax Talk

Stocks Come Off Highs as Apple Wait Counters Boost From Tax Reform Talk